Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

Director Dealings

27 Apr 2020 07:00

RNS Number : 8768K
PCI-PAL PLC
27 April 2020
 

 

PCI-PAL PLC

("PCI Pal", the "Group" or the "Company")

Director Dealings

 

PCI-PAL PLC (AIM: PCIP), the global provider of secure payment solutions, has been notified that William Good, Chief Financial Officer, dealt in ordinary shares of 1p in the Company ("Ordinary Shares") as follows: 

Director Name

Title

Date of purchase

Ordinary Shares purchased

Price dealt per Ordinary Share

Total Ordinary Shares held

% total voting rights of Company

William Good

Chief Financial Officer

24/04/2020

40,000

42.628 p

205,000

0.35%

 

The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provides further detail.

 

For further information, please contact:

 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

William Good - Chief Financial Officer

 

 

 

finnCap (Nominated Adviser and Broker)

 

+44 (0) 20 7227 0500

Marc Milmo/Simon Hicks (Corporate Finance)

Richard Chambers (Corporate Broking)

 

 

 

 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Paul Vann

+44 (0) 797 122 1972

 

tom.cooper@walbrookpr.com

 

 

 

About PCI Pal:

PCI Pal is a provider of secure payment solutions for contact centres and businesses taking Cardholder Not Present (CNP) payments. PCI Pal's globally accessible cloud platform empowers organisations to take payments securely without bringing their environments into scope of PCI DSS and other card payment data security rules and regulations.

With the entire product portfolio served from PCI Pal's cloud environment, integrations with existing telephony, payment, and desktop environments are light-touch, ensuring no degradation of service while achieving security and compliance.

PCI Pal has offices in London, Ipswich (UK) and Charlotte NC (USA).

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

William Good

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

PCI PAL PLC

b)

LEI:

213800XTX34IQYMYES95

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each

 

ISIN Code: GB0009737155

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

42.628 pence

40,000 shares

 

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

e)

Date of the transaction:

24 April 2020

f)

Place of the transaction:

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHPPUGPCUPUUBA
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.